Prospective pharmacoepidemiological evaluation of sirolimus as conversion immunosuppression after kidney transplantation in usual clinical practice:: Results of the ROAR™ trial

被引：0
|
作者：
Pescovitz, Mark [1 ]
Kasiske, Bertram [2 ]
Copley, Brian [3 ]
机构：
[1] Indiana Univ, Sch Med, Indianapolis, IN USA
[2] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA
[3] Wyeth Pharmaceut, Collegeville, PA USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2008年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：515 / 515
页数：1
相关论文
共 50 条
  • [1] Prospective pharmacoepidemiological analysis of sirolimus as primary immunosuppression after kidney transplantation in usual clinical practice:: Results of the ROAR™ trial
    Pescovitz, Mark
    Nashan, Bjorn
    Copley, Brian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 514 - 515
  • [2] A Prospective, Multinational Pharmacoepidemiological Study of Clinical Conversion to Sirolimus Immunosuppression after Renal Transplantation
    Kasiske, Bertram L.
    Nashan, Bjorn
    Rial, Maria Del Carmen
    Raffaele, Pablo
    Russ, Graeme
    Campistol, Josep
    Pescovitz, Mark D.
    Keown, Paul A.
    JOURNAL OF TRANSPLANTATION, 2012, 2012
  • [3] Results of a Prospective Randomized Trial of Sirolimus Conversion in Kidney Transplant Recipients on Early Corticosteroid Withdrawal
    Heilman, Raymond. L.
    Younan, Kerrie
    Wadei, Hani M.
    Mai, Martin L.
    Reddy, Kunam S.
    Chakkera, Harini A.
    Gonwa, Thomas A.
    TRANSPLANTATION, 2011, 92 (07) : 767 - 773
  • [4] Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs
    Flechner, Stuart M.
    Goldfarb, David
    Solez, Kim
    Modlin, Charles S.
    Mastroianni, Barbara
    Savas, Kathy
    Babineau, Denise
    Kurian, Sunil
    Salomon, Daniel
    Novick, Andrew C.
    Cook, Daniel J.
    TRANSPLANTATION, 2007, 83 (07) : 883 - 892
  • [5] Tacrolimus- versus sirolimus-based immunosuppression after simultaneous pancreas and kidney transplantation: 5-year results of a randomized trial
    Cantarovich, Diego
    Kervella, Delphine
    Karam, Georges
    Dantal, Jacques
    Blancho, Gilles
    Giral, Magali
    Garandeau, Claire
    Houzet, Aurelie
    Ville, Simon
    Branchereau, Julien
    Delbos, Florent
    Guillot-Gueguen, Cecile
    Volteau, Christelle
    Leroy, Maxime
    Renaudin, Karine
    Soulillou, Jean-Paul
    Hourmant, Maryvonne
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (06) : 1679 - 1690
  • [6] A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year
    Mendez, R
    Gonwa, T
    Yang, HC
    Weinstein, S
    Jensik, S
    Steinberg, S
    TRANSPLANTATION, 2005, 80 (03) : 303 - 309
  • [7] EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
    Guba, M.
    Pratschke, J.
    Hugo, C.
    Kraemer, B.
    Pascher, A.
    Pressmar, K.
    Hakenberg, O.
    Fischereder, M.
    Brockmann, J.
    Andrassy, J.
    Stangl, M.
    Banas, B.
    Jauch, K. -W.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 21 - 22
  • [8] Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation
    Guba, Markus
    Pratschke, Johann
    Hugo, Christian
    Kraemer, Bernhard K.
    Pascher, Andreas
    Pressmar, Katharina
    Hakenberg, Oliver
    Fischereder, Michael
    Brockmann, Jens
    Andrassy, Joachim
    Banas, Bernhard
    Jauch, Karl-Walter
    TRANSPLANT INTERNATIONAL, 2012, 25 (04) : 416 - 423
  • [9] EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
    Guba, Markus
    Pratschke, Johann
    Hugo, Christian
    Kraemer, Bernhard K.
    Pascher, Andreas
    Pressmar, Katharina
    Hakenberg, Oliver
    Fischereder, Michael
    Brockmann, Jens
    Andrassy, Joachim
    Stangl, Manfred
    Bernhard, Banas
    Jauch, Karl-Walter
    TRANSPLANT INTERNATIONAL, 2011, 24 : 250 - 250
  • [10] EARLY CONVERSION TO A SIROLIMUS-BASED, CALCINEURIN-INHIBITOR-FREE IMMUNOSUPPRESSION IN THE SMART TRIAL: OBSERVATIONAL RESULTS AT 24 AND 36 MONTHS AFTER TRANSPLANTATION
    Guba, M.
    Pratschke, J.
    Pressmar, K.
    Kraemer, B.
    Andrassy, J.
    Reinke, P.
    Hugo, C.
    Hakenberg, O.
    Fischereder, M.
    Pascher, A.
    Stangl, M.
    Banas, B.
    Jauch, K. -W.
    TRANSPLANT INTERNATIONAL, 2010, 23 : 60 - 60
12345